|
|
|
On The Cover
This product was posted in Diagnostic and Invasive Cardiology, September/October issue 2008
|
 |
|
| |
Boston Scientific, Abbott Offer New Everolimus-Eluting Coronary Stents
The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System and Abbott Vascular’s XIENCE V Everolimus Eluting Coronary Stent System, both for the treatment of coronary artery disease.
The PROMUS Stent is a private labeled XIENCE V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific under an agreement executed prior to the 2006 acquisition of the former Guidant Corp. by Boston Scientific.
Boston Scientific said the PROMUS Stent is highly deliverable, made from cobalt chromium, which allows for thinner struts without sacrificing strength or visibility.
Boston Scientific’s PROMUS Stent and Abbott’s XIENCE V Stent are identical products sold by the respective companies under different brand names. The PROMUS (XIENCE V) Stent is indicated for improving coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions (up to 28 mm long) with reference vessel diameter of 2.5 to 4.09 mm.
Company web site: www.bostonscientific.com, www.abbottvascular.com
|
|
This product was posted in Diagnostic and Invasive Cardiology, September/October issue 2008
|
 |
|
| |
LD EZ Designed to Remove Infected Cardiac Leads
Spectranetics Corp. recently announced the availability of its LLD EZ Lead Locking Device (LLD) for the removal of nonfunctional or infected pacing and defibrillation leads. The LLD EZ is designed to enable physicians to secure the entire lead creating traction to enable the removal process.
LLD EZ aims to provide a flexible solution to address the removal of leads from scar tissue holding them in place, employing a braided mesh that expands to secure leads along their hollow inner lumen permitting physicians to apply steady traction on the lead. The locking mechanism can be reversed or unlocked if the physician needs to remove the device from the lead or reposition it.
Company web site: www.spectranetics.com
|
|
This product was posted in Diagnostic and Invasive Cardiology, September/October issue 2008
|
 |
|
| |
Philips’ Hand-Carried Ultrasound Brings Premium Echo Imaging to Bedside
Philips Healthcare has developed a hand-carried ultrasound with reportedly advanced imaging quality. The CX50 CompactXtreme is set to commercially release in the fourth quarter of 2008.
Primarily designed for echocardiography, the CX50 was designed with many of the same features of the iE33 echocardiography system, providing clinicians a portable ultrasound that can be used for diagnosis.
The PureWave transducer, according to Philips, produces greater bandwidth and efficiency, yielding better imaging performance. This technology is designed to achieve greater penetration in patients who are traditionally difficult to image, such as obese patients or patients with emphysema. XRES adaptive imaging reportedly reduces noise and artifact.
Company web site: www.medical.philips.com
|
|
This product was posted in Diagnostic and Invasive Cardiology, September/October issue 2008
|
 |
|
| |
LUMEDX Offers Multi-modality, Web-Enabled Cardiology PACS
LUMEDX Corp. offers the CardioPACS 5.0, the latest version of its cardiology PACS software.
The multimodality, Web-enabled and vendor-neutral CardioPACS 5.0 offers new ways to manage images and data with a fully integrated suite of applications and modules.
With CardioPACS 5.0, physicians can view diagnostic-quality images in real time from any network-connected PC in any location the OR, cath lab, or in their offices, remote outreach or mobile clinics.
CardioPACS offers on-demand, real-time workstations where images for multiple clinical areas, such as the cathlab echo, nuclear, CT, MR, PET-CT and SPECT-CT can be accessed. The system reportedly allows high-speed access, high-quality images using MPEG4 compression algorithms.
The system also allows for single sign-on capability to multiple applications using Microsoft Windows Active Directory.
Company web site: www.lumedx.com
|
|
|
Feedback Welcome... Diagnostic and Invasive Cardiology welcomes your thoughts/comments.
E-mail: marketing@rcgpubs.com
Phone: 847.882.6336 Fax: 847.519.0166
Mail: Editor, Diagnostic and Invasive Cardiology, Reilly Communications Group, 16 East Schaumburg Road, Schaumburg, IL 60194-3536 |
|
eMail document
print document
request info